Suivre
Fiona Frame
Fiona Frame
Research Development Manager, Biomedical Science
Adresse e-mail validée de york.ac.uk
Titre
Citée par
Citée par
Année
Prostate cancer stem cells
SH Lang, FM Frame, AT Collins
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
2032009
Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells
AM Hirst, MS Simms, VM Mann, NJ Maitland, D O'connell, FM Frame
British journal of cancer 112 (9), 1536-1545, 2015
2012015
Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future
AM Hirst, FM Frame, M Arya, NJ Maitland, D O’Connell
Tumor Biology 37, 7021-7031, 2016
1862016
Apoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2
HA Rogoff, MT Pickering, FM Frame, ME Debatis, Y Sanchez, S Jones, ...
Molecular and cellular biology 24 (7), 2968-2977, 2004
1652004
Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancer
DE Butler, C Marlein, HF Walker, FM Frame, VM Mann, MS Simms, ...
Oncotarget 8 (34), 56698, 2017
1252017
Prostate cancer stem cells: do they have a basal or luminal phenotype?
NJ Maitland, FM Frame, ES Polson, JL Lewis, AT Collins
Hormones and Cancer 2, 47-61, 2011
1222011
Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/p21-mediated growth arrest response
JP Castillo, FM Frame, HA Rogoff, MT Pickering, AD Yurochko, ...
Journal of virology 79 (17), 11467-11475, 2005
852005
An epigenetic reprogramming strategy to resensitize radioresistant prostate cancer cells
C Peitzsch, M Cojoc, L Hein, I Kurth, K Mäbert, F Trautmann, B Klink, ...
Cancer research 76 (9), 2637-2651, 2016
752016
HDAC inhibitor confers radiosensitivity to prostate stem-like cells
FM Frame, D Pellacani, AT Collins, MS Simms, VM Mann, GDD Jones, ...
British journal of cancer 109 (12), 3023-3033, 2013
742013
Cancer stem cells, models of study and implications of therapy resistance mechanisms
FM Frame, NJ Maitland
Human Cell Transformation: Role of Stem Cells and the Microenvironment, 105-118, 2012
702012
Low temperature plasma: a novel focal therapy for localized prostate cancer?
AM Hirst, FM Frame, NJ Maitland, D O’Connell
BioMed research international 2014, 2014
642014
E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts
FM Frame, HA Rogoff, MT Pickering, WD Cress, TF Kowalik
Oncogene 25 (23), 3258-3266, 2006
632006
Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer
D Pellacani, RJ Packer, FM Frame, EE Oldridge, PA Berry, MC Labarthe, ...
Molecular cancer 10, 1-14, 2011
562011
Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cells
E Ulukaya, FM Frame, B Cevatemre, D Pellacani, H Walker, VM Mann, ...
PloS one 8 (5), e64278, 2013
482013
An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter …
S Hager, FM Frame, AT Collins, JE Burns, NJ Maitland
Human gene therapy 19 (8), 840-850, 2008
412008
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation
D Pellacani, D Kestoras, AP Droop, FM Frame, PA Berry, MG Lawrence, ...
Cell Death & Differentiation 21 (5), 761-773, 2014
372014
Expression of nitric oxide synthase III (eNOS) mRNA by human skin cells: melanocytes but not keratinocytes express eNOS mRNA
M Jackson, F Frame, R Weller, RC McKenzie
Archives of dermatological research 290, 350-352, 1998
361998
Effects on prostate cancer cells of targeting RNA polymerase III
JL Petrie, C Swan, RM Ingram, FM Frame, AT Collins, H Dumay-Odelot, ...
Nucleic Acids Research 47 (8), 3937-3956, 2019
322019
Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells
FM Frame, S Hager, D Pellacani, MJ Stower, HF Walker, JE Burns, ...
Experimental cell research 316 (19), 3161-3171, 2010
322010
Tumor heterogeneity and therapy resistance-implications for future treatments of prostate cancer
FM Frame, AR Noble, S Klein, HF Walker, R Suman, R Kasprowicz, ...
J. Cancer Metastasis Treat 3 (12), 302, 2017
282017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20